AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CLOFAZIMINE
12 registrations across 3 African markets— 12 active
Markets with CLOFAZIMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LEPROCULMIN | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Dec 2029 |
| TUBRAMAK 50 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2028 |
| CLOFAZIMINE TABLETS 100 mg MACLEODS | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2028 |
| TUBRAMAK 100 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2028 |
| CLOFAZIMINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| Clofazimine Tablet, Film-coated 50mg Tablet, Film-coated | 🌍WW | Macleods Pharmaceuticals Ltd | active | — |
| CLOFAZIMINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| Clofazimine Tablet, Film-coated 100mg Tablet, Film-coated | 🌍WW | Macleods Pharmaceuticals Ltd | active | — |
| Clofazimine | 🌍WW | Dong-A ST Co., Ltd. | active | — |
| CLOFAZIMINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
| Clofazimine | 🌍WW | Pen Tsao Chemical Industry Ltd | active | — |
| CLOFAZIMINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | MACLEODS PHARMACEUTICA LS LTD | active | — |
CLOFAZIMINE in Africa — Regulatory Overview
CLOFAZIMINE is registered across 3 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, WW, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.